Atlas Trials

Screening for High Frequency Malignant Disease

Clinical trial NCT05117840 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05117840
Sponsor
Guardant Health, Inc.
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2022-01-13
Primary completion
2026-12-31
Enrollment
12000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.